| Literature DB >> 27412903 |
Antonio H Frangieh1, Slayman Obeid1, Jelena-Rima Ghadri1, Yoichi Imori1, Fabrizio D'Ascenzo1, Marc Kovac1, Frank Ruschitzka1, Thomas F Lüscher1, Firat Duru1, Christian Templin2.
Abstract
BACKGROUND: ECG criteria differentiating Takotsubo cardiomyopathy (TTC) from mainly anterior myocardial infarction (MI) have been suggested; however, this was in small patient populations. METHODS ANDEntities:
Keywords: Takotsubo cardiomyopathy; differential diagnosis; electrocardiogram; myocardial infarction; stress‐induced cardiomyopathy
Mesh:
Year: 2016 PMID: 27412903 PMCID: PMC4937281 DOI: 10.1161/JAHA.116.003418
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Characteristics of the Total Study Population; Comparison Between MI and TTC
| Total TTC | Total MI |
| |
|---|---|---|---|
| N=200 | N=200 | ||
| Baseline characteristics | |||
| Age, y | 65.5±12.1 | 65.8±12.3 | 0.62 |
| Female | 182 (91) | 53 (27) | <0.001 |
| BMI, kg/m² | 24.5±4.4 | 28.4±6.0 | <0.001 |
| Cardiovascular risk factors and cardiovascular history | |||
| Hypertension | 109 (55) | 125 (64) | 0.10 |
| Diabetes mellitus | 18 (9) | 37 (19) | 0.006 |
| Ever‐smoker | 71 (36) | 114 (57) | <0.001 |
| Current smoker | 38 (19) | 86 (43) | <0.001 |
| Dyslipidemia | 52 (26) | 109 (56) | <0.001 |
| Positive family history of cardiovascular disease | 50 (25) | 53 (28) | 0.65 |
| Known CAD | 11 (6) | 31 (16) | 0.001 |
| Clinical and laboratory parameters | |||
| EF at admission (%) | 43±10 (N=193) | 51±11 (N=151) | <0.001 |
| Peak troponin level (ULN) | 21.0±27.7 (N=187) | 36.4±63.5 (N=200) | 0.002 |
| Peak CK level (ULN) | 2.5±7.3 (N=164) | 7.5±10.2 (N=200) | <0.001 |
| Peak CRP level, mg/L | 35.4±54.5 (N=173) | 67.5±109.9 (N=192) | 0.001 |
| In‐hospital complications | |||
| Cardiogenic shock | 16 (8) | 19 (10) | 0.60 |
| All‐cause mortality | 8 (4) | 10 (5) | 0.64 |
Depicted are counts, N incidence (%). BMI indicates body mass index; CAD, coronary artery disease; CK, creatine kinase; CRP, C‐reactive protein; EF, ejection fraction; MI, myocardial infarction; TTC, Takotsubo cardiomyopathy; ULN, upper limit of normal.
Mean±SD.
Figure 1Comparison of 1—ST‐elevation, 2—ST‐depression, and 3—T‐wave inversion in 12‐lead ECG between Takotsubo cardiomyopathy and myocardial infarction in the setting of STEMI and NSTEMI presentation. ACS indicates acute coronary syndromes; MI, myocardial infarction; NSTEMI, non ST‐elevation MI; STEMI, ST‐elevation MI.
Admission ECG Characteristics; Comparison Between MI and TTC
| Total TTC | Total MI |
| |
|---|---|---|---|
| N=200 | N=200 | ||
| Sinus rhythm | 194 (97) | 188 (94) | 0.23 |
| Atrial fibrillation | 5 (3) | 11 (6) | 0.20 |
| Axis | |||
| Normal | 162 (81) | 164 (82) | 0.90 |
| Left | 33 (17) | 27 (14) | 0.48 |
| QTc, ms | 457.3±36.5 | 439.9±37.2 | <0.001 |
| QT prolongation | 102 (51) | 84 (42) | 0.09 |
| Heart rate, bpm | 83±20 | 76±19 | <0.001 |
| PQ, ms | 165.3±31.4 | 153.9±48.7 | 0.006 |
| QRS, ms | 89.4±13.8 | 98.2±22.1 | <0.001 |
| RR, ms | 755±174 | 822±203 | 0.001 |
| Normal ECG | 28 (14) | 28 (14) | 1 |
| Q wave | 20 (10) | 29 (15) | 0.22 |
| ST‐elevation (STe) | 111 (56) | 106 (53) | 0.69 |
| STe with no concomitant ST depression or T wave inversion | 59 (30) | 23 (12) | <0.001 |
| STe inferior | 22 (11) | 41 (21) | 0.013 |
| STe lateral | 15 (8) | 9 (5) | 0.29 |
| STe anteroseptal | 43 (22) | 25 (13) | 0.023 |
| STe anterior | 45 (23) | 27 (14) | 0.026 |
| STe aVR | 7 (4) | 35 (18) | <0.001 |
| ST‐depression (STd) | 31 (16) | 106 (53) | <0.001 |
| STd with no concomitant ST elevation or T wave inversion | 8 (4) | 25 (13) | 0.003 |
| STd inferior | 15 (8) | 39 (19) | <0.001 |
| STd lateral | 19 (10) | 43 (22) | 0.001 |
| STd anteroseptal | 2 (1) | 10 (5) | 0.036 |
| STd anterior | 5 (3) | 38 (19) | <0.001 |
| STd in aVR (STe in ‐aVR) | 62 (31) | 6 (3) | <0.001 |
| T wave inversion (Tinv) | 90 (45) | 43 (22) | <0.001 |
| Sum of leads presenting Tinv | 2.20±0.16 | 2.29±2.46 | 0.71 |
| Tinv present in ≥5 leads | 60 (30) | 13 (7) | <0.001 |
| Tinv with no concomitant ST elevation or ST depression | 43 (22) | 24 (12) | 0.016 |
| Tinv inferior | 31 (16) | 18 (9) | 0.066 |
| Tinv lateral | 38 (19) | 11 (6) | <0.001 |
| Tinv anteroseptal | 4 (2) | 10 (5) | 0.17 |
| Tinv anterior | 43 (22) | 11 (6) | <0.001 |
Depicted are counts, N incidence (%). MI indicates myocardial infarction; TTC, Takotsubo cardiomyopathy.
Mean±SD.
QTc ≥440 ms and ≥460 ms for male and female sex, respectively.
More than 2 leads out of 3 in II‐III‐aVF.
More than 2 leads out of 4 in (I‐aVL‐V5‐V6).
More than 2 leads out of 3 in (V1‐V2‐V3).
More than 4 leads out of 6 in (V1‐V2‐V3‐V4‐V5‐V6).
Baseline ECG Characteristics; Comparison Between STE‐TTC and STEMI
| STE‐TTC | STEMI |
| |
|---|---|---|---|
| N=111 | N=106 | ||
| Sinus rhythm | 107 (96) | 99 (93) | 0.37 |
| Atrial fibrillation | 3 (3) | 6 (6) | 0.32 |
| Axis | |||
| Normal | 82 (74) | 83 (78) | 0.53 |
| Left | 26 (23) | 15 (14) | 0.09 |
| QTc, ms | 453±34 | 445±36 | 0.08 |
| QT prolongation | 52 (47) | 52 (49) | 0.79 |
| Heart rate, bpm | 87±22 | 81±20 | 0.031 |
| PQ, ms | 165±31 | 158±48 | 0.22 |
| QRS, ms | 88±17 | 102±24 | <0.001 |
| RR, ms | 720±154 | 776±13 | 0.023 |
| Q wave | 17 (15) | 19 (18) | 0.72 |
| ST‐elevation (STe) | |||
| STe with no concomitant ST depression or T wave inversion | 58 (52) | 22 (21) | <0.001 |
| STe inferior | 22 (20) | 40 (38) | 0.004 |
| STe lateral | 15 (14) | 7 (7) | 0.12 |
| STe anteroseptal | 42 (38) | 23 (22) | 0.012 |
| STe anterior | 44 (40) | 27 (26) | 0.03 |
| STe aVR | 6 (5) | 33 (31) | <0.001 |
| ST‐depression (STd) | 18 (16) | 73 (69) | <0.001 |
| STd inferior | 13 (12) | 33 (31) | <0.001 |
| STd lateral | 11 (10) | 27 (26) | 0.004 |
| STd anteroseptal | 2 (2) | 9 (9) | 0.031 |
| STd anterior | 2 (2) | 23 (22) | <0.001 |
| STd in aVR (STe in ‐aVR) | 48 (43) | 5 (5) | <0.001 |
| T wave inversion (Tinv) | 40 (36) | 18 (17) | 0.002 |
| Sum of leads presenting Tinv | 3.80±1.80 | 3.98±2.17 | 0.51 |
| Tinv present in ≥5 leads | 60 (30) | 13 (7) | <0.001 |
| Tinv inferior | 14 (13) | 6 (6) | 0.10 |
| Tinv lateral | 15 (14) | 5 (5) | 0.033 |
| Tinv anteroseptal | 1 (1) | 3 (3) | 0.36 |
| Tinv anterior | 20 (18) | 5 (5) | 0.003 |
Depicted are counts, N incidence (%). STEMI indicates ST‐elevation myocardial infarction; STE‐TTC, ST‐elevation Takotsubo cardiomyopathy.
Mean±SD.
QTc ≥440 ms and ≥460 ms for male and female sex, respectively.
More than 2 leads out of 3 in II‐III‐aVF.
More than 2 leads out of 4 in (I‐aVL‐V5‐V6).
More than 2 leads out of 3 in (V1‐V2‐V3).
More than 4 leads out of 6 in (V1‐V2‐V3‐V4‐V5‐V6).
Diagnostic Values of Combined Electrocardiographic Findings for Differentiating TTC From STEMI and NSTEMI
| Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
| |
|---|---|---|---|---|---|
| TTC vs STEMI in the setting of STe‐ECG | |||||
| Specific criteria for TTC | |||||
| Tinv (any lead) | 36 | 83 | 63 | 55 | 0.002 |
| STe in –aVR | 43 | 95 | 91 | 62 | <0.001 |
| STe in ‐aVR and No STe in V1 | 38 | 95 | 89 | 59 | <0.001 |
| STe in ‐aVR and no STe in V1 and no abnormal Q‐waves | 32 | 97 | 92 | 58 | <0.001 |
| STe in ‐aVR and STe in inferior | 14 | 98 | 89 | 52 | 0.001 |
| STe in ‐aVR and STe in anterior | 19 | 98 | 91 | 54 | <0.001 |
| STe in ‐aVR and STe in anteroseptal | 12 | 100 | 100 | 52 | <0.001 |
| Specific criteria for STEMI | |||||
| STd (any lead) | 69 | 84 | 80 | 74 | <0.001 |
| STd in inferior | 31 | 88 | 72 | 57 | <0.001 |
| STe in aVR | 31 | 95 | 85 | 59 | <0.001 |
| STd in I and aVL | 34 | 96 | 90 | 64 | <0.001 |
| STe in aVR and STd in inferior | 13 | 96 | 74 | 54 | 0.03 |
| STe in aVR and STd in anterior | 11 | 98 | 86 | 54 | 0.005 |
| STd in V2, V3, and V4 | 24 | 100 | 100 | 76 | <0.001 |
| TTC vs NSTEMI in the setting of non STe‐ECG | |||||
| Specific criteria for TTC | |||||
| Tinv in V5 and V6 | 39 | 90 | 80 | 61 | <0.001 |
| Tinv in ≥5 leads (any leads) | 36 | 92 | 80 | 60 | <0.001 |
| Tinv in I and aVL | 29 | 94 | 81 | 58 | <0.001 |
| Tinv in I, aVL, V5, and V6 | 17 | 97 | 83 | 55 | 0.002 |
| STe in –aVR | 16 | 99 | 93 | 55 | <0.001 |
| STe in ‐aVR and Tinv (any lead) | 8 | 100 | 100 | 53 | 0.006 |
| Specific criteria for NSTEMI | |||||
| STd (with no Tinv in any lead) | 25 | 91 | 74 | 53 | 0.006 |
| STd in anterior | 16 | 97 | 83 | 52 | 0.005 |
| STd in V2 and V3 | 11 | 99 | 91 | 51 | 0.01 |
NPV indicates negative predictive value; NSTEMI, non ST‐elevation myocardial infarction; PPV, positive predictive value; STd, ST‐depression; STe, ST‐elevation; STEMI, ST‐elevation myocardial infarction; Tinv, T wave inversion; TTC, Takotsubo cardiomyopathy.
More than 2 leads out of 3 in II‐III‐aVF.
More than 4 leads out of 6 in (V1‐V2‐V3‐V4‐V5‐V6).
More than 2 leads out of 3 in (V1‐V2‐V3).
Baseline ECG Characteristics; Comparison Between NSTE‐TTC and NSTEMI
| NSTE‐TTC | NSTEMI |
| |
|---|---|---|---|
| N=89 | N=94 | ||
| Sinus rhythm | 87 (98) | 89 (95) | 0.45 |
| Atrial fibrillation | 2 (2) | 5 (5) | 0.45 |
| Axis | |||
| Normal | 80 (90) | 81 (86) | 0.50 |
| Left | 7 (8) | 12 (13) | 0.34 |
| QTc, ms | 463±38 | 434±38 | <0.001 |
| QT prolongation | 50 (56) | 32 (34) | 0.005 |
| Heart rate, bpm | 78±18 | 71±17 | 0.004 |
| PQ, ms | 165±32 | 148±49 | 0.008 |
| QRS, ms | 90±15 | 94±19 | 0.14 |
| RR, ms | 802±190 | 874±191 | 0.014 |
| Normal ECG | 28 (32) | 28 (30) | 0.87 |
| ST‐depression (STd) | 13 (15) | 33 (35) | 0.002 |
| STd with no concomitant ST elevation or T wave inversion | 8 (9) | 16 (17) | 0.13 |
| STd inferior | 2 (2) | 6 (6) | 0.28 |
| STd lateral | 11 (12) | 20 (21) | 0.12 |
| STd anteroseptal | 0 | 1 (1) | 1 |
| STd anterior | 3 (3) | 15 (16) | 0.005 |
| STd in aVR (STe in ‐aVR) | 14 (16) | 1 (1) | <0.001 |
| T wave inversion (Tinv) | 50 (56) | 25 (27) | <0.001 |
| Sum of leads presenting Tinv | 3.04±3.11 | 1.37±2.11 | <0.001 |
| Tinv present in ≥5 leads | 32 (36) | 8 (9) | <0.001 |
| Tinv with no concomitant ST depression | 43 (49) | 24 (26) | 0.002 |
| Tinv inferior | 17 (19) | 12 (13) | 0.31 |
| Tinv lateral | 23 (26) | 6 (6) | <0.001 |
| Tinv anteroseptal | 3 (3) | 7 (7) | 0.33 |
| Tinv anterior | 23 (26) | 6 (6) | <0.001 |
Depicted are counts, N incidence (%). NSTEMI indicates non ST‐elevation myocardial infarction; NSTE‐TTC, non ST‐elevation Takotsubo cardiomyopathy.
Mean±SD.
QTc ≥440 ms and ≥460 ms for male and female sex, respectively.
More than 2 leads out of 3 in (II‐III‐aVF).
More than 2 leads out of 4 in (I‐aVL‐V5‐V6).
More than 2 leads out of 3 in (V1‐V2‐V3).
More than 4 leads out of 6 in (V1‐V2‐V3‐V4‐V5‐V6).
Review of Proposed Differentiating Electrocardiographic Criteria From Major Studies
| Reference | Study Description | Onset of Pain | No. of Patients | Origin of ST‐Segment | ECG Criteria for Identifying ACS/TTC | Sensitivity | Specificity | Testing of Proposed Criteria in Our Cohort |
| |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensitivity | Specificity | |||||||||
| Mugnai et al Journal of Electrocardiology 2015 | TTC vs AMI | <12 h |
27 (STEMI) | J point | Lack of STe in lead V1, absence of abnormal Q waves and STd in aVR | 40 | 95 | 25 | 98.1 | <0.001 |
| Parkkonen et al Journal of Electrocardiology 2014 | TTC vs AMI | <24 h |
96 (AMI) | J point | Lack of STe in lead V1 and STe <2 mm in V2 | 63 | 93 | 57.5 | 100 | <0.001 |
| Jim et al Heart Vessels 2009 | TTC vs AMI | <12 h |
27 (AMI) | 80 ms from J point | STe in lead II >1 mm | 62.5 | 92.6 | 12.5 | 84.6 | 0.644 |
| Tamura et al Am J Cardiol 2011 | TTC vs AMI | <6 h |
280 (AMI) | 80 ms from J point | STe >1 mm in >1 V3‐V5 and no STd >1 mm in V1 | 74.2 | 80.6 | 36.5 | 73.1 | 0.252 |
| Guerra et al Am J Cardiol 2013 | TTC vs ACS | <12 h |
45 (ACS) | J‐point | ∑STe V4‐V6/∑STe V1‐V3 | Non discriminative | 64.3 | 21.5 | 0.002 | |
| Kosuge et al JACC 2010 | TTC vs AMI | <6 |
342 (AMI) | 80 ms from J‐point | STd in aVR, and no STe in V1 | 91 | 95 | 28 | 96.2 | <0.001 |
| Ogura et al Circ J 2003 | TTC vs AMI |
13 (AMI) | 80 ms from J‐point | Absence of reciprocal changes | 100 | 69 | 92.5 | 44.2 | <0.001 | |
| ∑STe V4‐V6/∑STe V1‐V3 ≥1 | 80 | 77 | 64.3 | 73.1 | <0.001 | |||||
| Combined criteria | 100 | 61.3 | 86.5 | <0.001 | ||||||
ACS indicates acute coronary syndromes; AMI, anterior myocardial infarction; STd, ST‐segment depression; STe, ST‐segment elevation; STEMI, ST‐segment elevation myocardial infarction; TTC, Takotsubo cardiomyopathy.
Onset of pain <12 h, origin of ST‐segment J point.
Figure 2Algorithm favoring the diagnosis of Takotsubo based on highly specific admission ECG criteria in the setting of acute coronary syndrome (STEMI and NSTEMI). NSTEMI indicates non ST‐elevation myocardial infarction; STEMI, ST‐elevation myocardial infarction; STe, ST‐segment elevation; STd, ST‐segment depression; TTC, Takotsubo cardiomyopathy. *100% specificity and 100% positive predictive value; †More than 2 leads out of 3 in II‐III‐aVF; ‡More than 4 leads out of 6 in (V1‐V2‐V3‐V4‐V5‐V6); xMore than 2 leads out of 3 in (V1‐V2‐V3).
Figure 3ECG examples for the most specific combination of criteria in each group of patients. Group 1: Takotsubo with ST‐elevation (STE‐TTC): STe in –aVR and STe in anteroseptal lead; Group 2: ST‐elevation myocardial infarction (STEMI): STd in V2, V3 and V4 (among others); Group 3: Takotsubo without ST‐elevation (NSTE‐TTC): STe in –aVR and Tinv (any lead); Group 4: Non ST‐elevation myocardial infarction (NSTEMI): STd in V2, V3.